Siemens said Wednesday it will transfer 30% of Siemens Healthineers shares to Siemens shareholders, giving up its controlling stake in the imaging and diagnostics company.
The move will allow Siemens, which now holds a 67% stake in Siemens Healthineers, to focus on its core technology portfolio with greater capital allocation flexibility, the German company said. “This will help us to accelerate our growth,” Siemens CEO Roland Busch said in a LinkedIn post.
Siemens will become a significant minority shareholder in Siemens Healthineers.
Siemens Healthineers CEO Bernd Montag, in a LinkedIn post, called the decision a “natural next step in our journey to becoming a fully independent company,” following an initial public offering in 2018.
The decision follows a strategic review of how both companies can best realize their full potential, accelerate transformation and reach new areas of growth, Siemens said.
“Each of the two companies has a strong financial profile offering strategic flexibility to accelerate value creation in their respective core markets through tailored capital allocation – enabling both organizations to operate with greater agility and focus,” Siemens CFO Ralf Thomas said in a statement.
Further details on the structure and timing of the transaction will be provided early in the second quarter of calendar year 2026. The transaction is subject to regulatory reviews and approvals by shareholder meetings of both Siemens and Siemens Healthineers.
Siemens Healthineers earlier this month reported a 4% year-over-year decline in fourth-quarter net income on roughly flat revenue, pointing to a challenging environment marked by higher tariffs.
